MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.220
-0.060 (-4.69%)
At close: Aug 28, 2026, 4:00 PM EDT
1.213
-0.008 (-0.61%)
After-hours: Aug 28, 2026, 7:30 PM EDT
MaxCyte Employees
MaxCyte had 91 employees as of December 31, 2025. The number of employees decreased by 23 or -20.18% compared to the previous year.
Employees
91
Change (1Y)
-23
Growth (1Y)
-20.18%
Revenue / Employee
$341,220
Profits / Employee
-$391,604
Market Cap
125.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 91 | -23 | -20.18% |
| Dec 31, 2024 | 114 | -29 | -20.28% |
| Dec 31, 2023 | 143 | 18 | 14.40% |
| Dec 31, 2022 | 125 | 41 | 48.81% |
| Dec 31, 2021 | 84 | 19 | 29.23% |
| Mar 31, 2021 | 65 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 753 |
| Quanterix | 450 |
| Pulmonx | 296 |
| Apyx Medical | 205 |
| LENSAR | 150 |
| Quantum-Si incorporated | 145 |
| Owlet | 114 |
| Hyperfine | 102 |
MXCT News
- 9 days ago - MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies - GlobeNewsWire
- 11 days ago - MaxCyte reports Q2 EPS (8c), consensus (9c) - TheFly
- 16 days ago - MaxCyte Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - MaxCyte Earnings release: Q2 2026 - Filings
- 16 days ago - MaxCyte Quarterly report: Q2 2026 - Filings
- 16 days ago - MaxCyte Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 16 days ago - MaxCyte Slides: Corporate presentation - Filings
- 5 weeks ago - MaxCyte enters technology license partnership with Genentech - TheFly